RxSight, Inc. Expands Commercial Leadership with Addition of Steve Everly as Vice-President of U.S. Sales
August 17, 2021 16:05 ET
|
Rxsight, Inc.
ALISO VIEJO, Calif., Aug. 17, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company, today announced that Steve Everly has joined the company as its Vice...
RxSight Announces Appointments to its Board of Directors
August 10, 2021 20:05 ET
|
Rxsight, Inc.
ALISO VIEJO, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company, today announced the appointment of three new members to its Board of Directors effective...
RxSight, Inc. Announces Closing of Initial Public Offering and Partial Exercise of the Underwriters’ Option to Purchase Additional Shares
August 04, 2021 16:05 ET
|
Rxsight, Inc.
ALISO VIEJO, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company, today announced the closing of its initial public offering of 7,350,000 shares of common...
RxSight, Inc. Announces Pricing of Initial Public Offering
July 29, 2021 22:17 ET
|
Rxsight, Inc.
ALISO VIEJO, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company, today announced the pricing of its initial public offering of 7,350,000 shares of common...